Keepin touch

Whether you have a question, comment, suggestion or any problem falling within the competence of the Government, send us your message and we will try to respond as soon as possible. If your problem does not fall within our competence, we will forward your message to the competent institution.

The Government of the Republic of Serbia

In the service of citizens

Data for production of "Sputnik V" in Serbia opened to Torlak

Belgrade, 5 April 2021

Minister without portfolio in charge of innovations and technological development and President of the Intergovernmental Committee for Cooperation with Russia Nenad Popovic announced that an agreement was signed today by which the Russian side agreed on transmission of data on procedures and technologies necessary for the production of the "Sputnik V" vaccine in the Republic of Serbia.

The Torlak Institute has signed a Technology Transfer Agreement with the Russian Direct Investment Fund and the Russian pharmaceutical company Generium, which makes this possible.

Popovic pointed out that from this moment, data related to the production of the "Sputnik V" vaccine, which was developed by the most renowned Russian institute for virology "Gamaleya", have been opened for Torlak.

It is about sensitive and confidential data that can be exchanged only by partners who have huge mutual trust, the Minister assessed and announced that three validation series of the "Sputnik V" vaccine will be produced at the Torlak Institute in April.

According to him, samples from these validation series will be sent for quality control to the Gamaleya Institute in Moscow, and after that institute will confirm the validity of the samples produced in Torlak, upon which the Torlak Institute will start producing the vaccine.

We expect that to happen by 20 May this year, Popovic said and pointed out that in that way, Serbia would become the first country in Europe to produce the "Sputnik V" vaccine.